DEF 14AThe Ballot
Kymera Therapeutics, Inc. files DEF 14A
Filed Apr 27, 2023 · 3y ago · Accession 0001193125-23-122116
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Kymera Therapeutics, Inc.
- Ticker
- KYMR
- CIK
- 1815442
- Form type
- DEF 14A
- Filing date
- Apr 27, 2023
- Report date
- —
- Document
- d302294ddef14a.htm
- Size
- 2.1 MB